TickerFactsScreenerDevelopers

Immunovant, Inc. (IMVT) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2018: -$411.0K2019: $7.34M2020: $94.07M2021: $391.48M2022: $469.82M2023: $362.49M2024: $617.76M2025: $707.45M2026: $852.59M$852.59M
2018Shareholders' Equity (USD)2026
Fiscal YearShareholders' EquityChange YoY
2026$852.59M+20.5%
2025$707.45M+14.5%
2024$617.76M+70.4%
2023$362.49M-22.8%
2022$469.82M+20.0%
2021$391.48M+316.2%
2020$94.07M+1181.8%
2019$7.34M+1885.6%
2018-$411.0K—